Information de reference pour ce titreAccession Number: | 01451458-201601150-00022.
|
Author: | Cao, Wei; Mehraj, Vikram; Trottier, Benoit; Baril, Jean-Guy; Leblanc, Roger; Lebouche, Bertrand; Cox, Joseph; Tremblay, Cecile; Lu, Wei; Singer, Joel; Li, Taisheng; Routy, Jean-Pierre; the Montreal Primary HIV Infection Study Group; Vezina, S.; Charest, L.; Milne, M.; Huchet, E.; Lavoie, S.; Friedman, J.; Duchastel, M.; Villielm, F.; Cote, P.; Potter, M.; Lessard, B.; Charron, M. A.; Dufresne, S.; Turgeon, M. E.; Rouleau, D.; Labrecque, L.; Fortin, C.; de Pokomandy, A.; Hal-Gagne, V.; Munoz, M.; Deligne, B.; Martel-Laferriere, V.; Gilmore, N.; Fletcher, M.; Szabo, J.
|
Institution: | (1)Research Institute of the McGill University Health Centre (2)Chronic Viral Illness Service (3)Division of Hematology, McGill University Health Centre (4)Clinique Medicale l'Actuel (5)Clinique Medicale Quartier Latin (6)Clinique Medicale OPUS (7)CHUM Research Centre (8)Department of Microbiology and Immunology, University of Montreal, Quebec, Canada (9)School of Population and Public Health, University of British Columbia, Vancouver, Canada (10)Department of Infectious Diseases, Peking Union Medical College Hospital, Beijing, China
|
Title: | |
Source: | Clinical Infectious Diseases. 62(2):250-257, January 15, 2016.
|
Abstract: | Background. CD8 T-cell counts remain elevated in human immunodeficiency virus (HIV) infection even after long-term antiretroviral therapy (ART), which is associated with an increased risk of non-AIDS-related events. We assessed the impact of ART initiation in early versus chronic HIV infection on trajectories of CD8 cell counts over time.
Methods. Of 280 individuals enrolled during primary HIV infection (PHI), 251 were followed up for 24 months; 84 started ART before 6 months of infection (eART), 49 started between 6 and 24 months, and 118 remained untreated. Plasma HIV viral load (VL), CD4 and CD8 cell counts were assessed at each study visit. CD8 counts were also examined in 182 age-matched HIV-infected individuals who started ART during chronic infection and maintained undetectable plasma VL for >=5 years.
Results. At PHI baseline, higher CD8 cell counts were associated with more recent infection (P = .02), higher CD4 cell counts (P < .001), and higher VL (P < .001). The CD8 count in the eART group decreased from 797 to 588 cells/[micro]L over 24 months (P < .001), to a level lower than that in untreated PHI (834 cells/[micro]L; P = .004) or in long-term-treated patients with chronic HIV infection (743 cells/[micro]L; P = .047). More prominent CD4 T-cell recovery was observed in the eART group than in the delayed ART group.
Conclusions. ART initiated in early HIV infection is associated with improved resolution of CD8 T-cell elevation compared with long-term ART initiated in chronic infection. Early ART may help reduce the risk of non-AIDS-related events by alleviating this elevation.
(C) Copyright Oxford University Press 2016.
|
Author Keywords: | HIV; primary infection; antiretroviral therapy; CD8 T-cell count; CD4/CD8 ratio.
|
References: | 1. Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity 2013; 39:633-45.
2. Lempicki RA, Kovacs JA, Baseler MW, et al.. Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients. Proc Natl Acad Sci U S A 2000; 97:13778-83.
3. Hellerstein M, Hanley MB, Cesar D, et al.. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med 1999; 5:83-9.
4. Bastidas S, Graw F, Smith MZ, Kuster H, Gunthard HF, Oxenius A. CD8+ T cells are activated in an antigen-independent manner in HIV-infected individuals. J Immunol 2014; 192:1732-44.
5. Srinivasula S, Lempicki RA, Adelsberger JW, et al.. Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes. Blood 2011; 118:262-70.
6. Peretz Y, He Z, Shi Y, et al.. CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction. PLoS Pathog 2012; 8:e1002840.
7. Brenchley JM, Karandikar NJ, Betts MR, et al.. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003; 101:2711-20.
8. Desai S, Landay A. Early immune senescence in HIV disease. Curr HIV/AIDS Rep 2010; 7:4-10.
9. Mercier F, Boulassel MR, Yassine-Diab B, et al.. Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7R[proportional to] on central and effector memory CD+ and CD8+ T cell subsets. Clin Exp Immunol 2008; 152:72-80.
10. Emu B, Moretto WJ, Hoh R, et al.. Composition and function of T cell subpopulations are slow to change despite effective antiretroviral treatment of HIV disease. PLoS One 2014; 9:e85613.
11. Ronsholt FF, Ullum H, Katzenstein TL, Gerstoft J, Ostrowski SR. T-cell subset distribution in HIV-1-infected patients after 12 years of treatment-induced viremic suppression. J Acquir Immune Defic Syndr 2012; 61:270-8.
12. Helleberg M, Kronborg G, Ullum H, Ryder LP, Obel N, Gerstoft J. Course and clinical significance of CD8+ T-cell counts in a large cohort of HIV-infected individuals. J Infect Dis 2015; 211:1726-34.
13. Serrano-Villar S, Sainz T, Lee SA, et al.. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog 2014; 10:e1004078.
14. Serrano-Villar S, Gutierrez C, Vallejo A, et al.. The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression. J Infect 2013; 66:57-66.
15. Jenabian MA, El-Far M, Vyboh K, et al.. Immunosuppressive tryptophan catabolism and gut mucosal dysfunction following early HIV infection. J Infect Dis 2015; 212:355-66.
16. Catalfamo M, Wilhelm C, Tcheung L, et al.. CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7. J Immunol 2011; 186:2106-16.
17. Mussini C, Lorenzini P, Cozzi-Lepri A, et al.. CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study. Lancet HIV 2015; 2:e98-106.
18. Strain MC, Little SJ, Daar ES, et al.. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis 2005; 191:1410-8.
19. Jain V, Hartogensis W, Bacchetti P, et al.. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis 2013; 208:1202-11.
20. Cao W, Mehraj V, Vyboh K, Li T, Routy JP. Antiretroviral therapy in primary HIV-1 infection: Influences on immune activation and gut mucosal barrier dysfunction. AIDS Rev 2015; Accepted.
21. Utay J, Ananworanich J, Slike B, et al.. Inflammation persists despite early initiation of ART in acute HIV infection [abstract 47]. Presented at: 22nd Conference on Retroviruses and Opportunistic Infections; 23-24 February 2015; Seattle, WA.
22. Boulassel MR, Mercier F, Gilmore N, Routy JP. Immunophenotypic patterns of CD8+ T cell subsets expressing CD8[proportional to] and IL-7R[proportional to] in viremic, aviremic and slow progressor HIV-1-infected subjects. Clin Immunol 2007; 124:149-57.
23. Fiebig EW, Wright DJ, Rawal BD, et al.. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17:1871-9.
24. Plana M, Garcia F, Gallart T, et al.. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection. AIDS 2000; 14:1921-33.
25. Lee SA, Sinclair E, Jain V, et al.. Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection. J Infect Dis 2014; 210:374-82.
26. Horvath S, Levine AJ. HIV-1 infection accelerates age according to the epigenetic clock. J Infect Dis 2015.
27. Nolz JC, Harty JT. IL-15 regulates memory CD8+ T cell O-glycan synthesis and affects trafficking. J Clin Invest 2014; 124:1013-26.
28. Lu W, Mehraj V, Vyboh K, Cao W, Li T, Routy JP. CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients. J Int AIDS Soc 2015; 18:20052.
|
Language: | English.
|
Document Type: | HIV/AIDS: Editor's choice.
|
Journal Subset: | Clinical Medicine. Life & Biomedical Sciences.
|
ISSN: | 1058-4838
|
DOI Number: | https://dx.doi.org/10.1093/cid/c...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|